Werewolf Therapeutics, Inc.·4

Jul 2, 8:26 AM ET

Karunatilake Chulani 4

4 · Werewolf Therapeutics, Inc. · Filed Jul 2, 2021

Insider Transaction Report

Form 4
Period: 2021-07-01
Karunatilake Chulani
Chief Technology Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-07-01+272,000272,000 total
    Exercise: $19.23Exp: 2031-06-30Common Stock (272,000 underlying)
Footnotes (1)
  • [F1]The option was granted on July 1, 2021. The shares underlying the option vest over four years, with one-fourth of the shares vesting on the first anniversary of the date of grant and the remaining shares vesting in equal monthly installments thereafter.

Documents

1 file
  • 4
    wf-form4_162522876528536.xmlPrimary

    FORM 4